Bio-Thera adheres to the concept of "Innovation for Life" and is committed to developing a new generation of innovative drugs and biosimilars based on the research findings of modern biological sciences for the treatment of tumors, autoimmune diseases, cardiovascular diseases, ophthalmology and other major diseases that threaten human life or health.

Bio-Thera focuses on the global market and currently has multiple products undergoing global clinical research. We cooperate with the world's leading pharmaceutical companies and leverage our partners' mature business networks and sales systems to jointly explore the international market. In addition, Bio-Thera has a mature R&D platform, clinical development platform and commercialization platform. We are also actively looking for high-quality drug candidates at home and abroad that are suitable for the Chinese market.